共 50 条
- [2] Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cycles of Anthracycline and Cyclophosphamide (AC) ChemotherapyONCOLOGIST, 2020, 25 (03): : E589 - E597Schwartzberg, LeeNavari, RudolphClark-Snow, RebeccaArkania, EkaterineRadyukova, IrenaPatel, KamalVoisin, DanielRizzi, GiadaWickham, RitaGralla, Richard J.Aapro, MattiRoeland, Eric
- [3] EFFICACY OF NEPA, THE FIRST COMBINATION ANTIEMETIC AGENT, IN PATIENTS WITH BREAST CANCER RECEIVING ANTHRACYCLINE/CYCLOPHOSPHAMIDE (AC) OR NON-AC CHEMOTHERAPYBREAST, 2015, 24 : S60 - S60Rugo, HopeAapro, MattiRossi, GiorgiaRizzi, Giada
- [4] Efficacy of intravenous (IV) NEPA and oral NEPA, fixed NK1/5-HT3 receptor antagonist (RA) combination agents, for prevention of chemotherapy-induced nausea and vomiting (CINV) following anthracycline-cyclophosphamide (AC)-based chemotherapyCANCER RESEARCH, 2020, 80 (04)Aapro, MattiSchwartzberg, Lee
- [5] Acute care and hydration due to chemotherapy-induced nausea and vomiting (CINV) among patients receiving NEPA prophylaxis for anthracycline plus cyclophosphamide (AC).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)Roeland, EricNavari, Rudolph M.Ruddy, Kathryn JeanLeBlanc, Thomas WilliamClark-Snow, Rebecca AnneWickham, Rita S.Binder, GaryBailey, William L.Schwartzberg, Lee S.
- [6] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC)-based chemotherapyJOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Schnadig, Ian D.Modiano, Manuel R.Poma, AllenArora, SujataSchwartzberg, Lee Steven
- [8] Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients (pts) receiving anthracycline-cyclophosphamide (AC) based chemotherapy.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)Powers, DanielSchnadig, Ian D.Modiano, Manuel R.Arora, SujataSchwartzberg, Lee Steven
- [10] Prolonged usage of NEPA for prevention of long-delayed CINV in patients receiving highly emetogenic chemotherapyANNALS OF ONCOLOGY, 2024, 35 : S1599 - S1599Xu, L.Sun, Y.Meng, F.Liu, C.Guan, S.Zhong, D.Zhang, L.